Categorical improvements in disease severity in patients with major depressive disorder treated with vilazodone: post hoc analysis of four randomized, placebo-controlled trials

Categorical improvements in disease severity in patients with major depressive disorder treated with vilazodone: post hoc analysis of four randomized, placebo-controlled trials

Suresh Durgam,1 Changzheng Chen,1 Carl P Gommoll,1 John Edwards,1 Leslie Citrome2 1Allergan, Jersey City, NJ, USA; 2Department of Psychiatry and Behavioral Sciences, New York Medical College, Valhalla, NY, USA Background: In three 8-week studies of vilazodone 40 mg/d (NCT00285376, NCT...

Full description

Saved in:
Bibliographic Details
Main Authors: Durgam S, Chen C, Gommoll CP, Edwards J, Citrome L
Format: Article
Language:English
Published: Dove Medical Press 2016-12-01
Series:Neuropsychiatric Disease and Treatment
Subjects:
depression
antidepressant
global improvement
clinical trial
Online Access:https://www.dovepress.com/categorical-improvements-in-disease-severity-in-patients-with-major-de-peer-reviewed-fulltext-article-NDT
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://www.dovepress.com/categorical-improvements-in-disease-severity-in-patients-with-major-de-peer-reviewed-fulltext-article-NDT

Similar Items